Evidence map›Paper›PMID 22069648›Full record

ReviewToxins2010

Shiga toxins: intracellular trafficking to the ER leading to activation of host cell stress responses.

Moo-Seung Lee, Rama P Cherla, Vernon L Tesh

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Enhanced Large-Scale Production ofJournal of microbiology and biotechnology · 2021
    Article
  5. Article
  6. Review
  7. Review
  8. LPS-primed CD11bScientific reports · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Moo-Seung LeeDepartment of Microbial and Molecular Pathogenesis, Texas A & M Health Science Center, 407 Joe H. Reynolds Medical Building, College Station, TX, 77843-1114, USA. mlee@medicine.tamhsc.edu
Rama P Cherla
Vernon L Tesh
Texas A&M Health Science Center · US

Funding

Pathogenic Mechanisms of Shiga ToxinsR01AI034530 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI TESH, VERNON L. · 2001 to 2010
$2.2M
NIAID NIH HHS 5R01 AI34530NIAID NIH HHS R01 AI034530
6 · The paper itself

Abstract

Despite efforts to improve hygenic conditions and regulate food and drinking water safety, the enteric pathogens, Shiga toxin-producing Escherichia coli (STEC) and Shigella dysenteriae serotype 1 remain major public health concerns due to widespread outbreaks and the severity of extra-intestinal diseases they cause, including acute renal failure and central nervous system complications. Shiga toxins are the key virulence factors expressed by these pathogens mediating extra-intestinal disease. Delivery of the toxins to the endoplasmic reticulum (ER) results in host cell protein synthesis inhibition, activation of the ribotoxic stress response, the ER stress response, and in some cases, the induction of apoptosis. Intrinsic and/or extrinsic apoptosis inducing pathways are involved in executing cell death following intoxication. In this review we provide an overview of the current understanding Shiga toxin intracellular trafficking, host cellular responses to the toxin and ER stress-induced apoptosis with an emphasis on recent findings.

Indexed as

AnimalsApoptosisEndoplasmic ReticulumEndoplasmic Reticulum StressHumansProtein TransportRibosomesShiga ToxinsShiga ToxinsapoptosisER stress responseretrograde transportribotoxic stress responseShiga toxins

Identifiers

PMID22069648
PMCPMC3153247
OpenAlexW2144758760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.